These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 8765705)
21. The role of testosterone in cyclosporine-induced osteopenia. Bowman AR; Sass DA; Dissanayake IR; Ma YF; Liang H; Yuan Z; Jee WS; Epstein S J Bone Miner Res; 1997 Apr; 12(4):607-15. PubMed ID: 9101372 [TBL] [Abstract][Full Text] [Related]
24. Infectious complications of immunosuppressive medications in organ transplant recipients. Green M; Michaels MG Pediatr Infect Dis J; 2007 May; 26(5):443-4. PubMed ID: 17468657 [No Abstract] [Full Text] [Related]
25. Osteoporosis after solid organ and bone marrow transplantation. Cohen A; Shane E Osteoporos Int; 2003 Aug; 14(8):617-30. PubMed ID: 12908095 [TBL] [Abstract][Full Text] [Related]
26. [Risk factors conditioning the incidence and severity of cyclosporine A-induced gingival overgrowth and methods of prevention]. Bartoli F; Castronovo G; Stabile A Minerva Stomatol; 2004 Apr; 53(4):165-70. PubMed ID: 15107773 [TBL] [Abstract][Full Text] [Related]
27. [Is it possible to prevent kidney problems caused by immunosuppression?]. Aitio ML Duodecim; 2000; 116(5):511-9. PubMed ID: 11787104 [No Abstract] [Full Text] [Related]
28. [Folliculitis in a patient undergoing kidney transplantation]. Ojeda-Vargas M; Monzón-Moreno C; Rodríguez J; Borrego L; Soler E; Martín-Sánchez AM Enferm Infecc Microbiol Clin; 1995 Dec; 13(10):637. PubMed ID: 8808485 [No Abstract] [Full Text] [Related]
29. [The risk of malignancy after organ transplantation]. Gürlich R; Novotný J; Stríz I; Honsová E; Oliverius M; Janousek L; Pokorná E; Maruna P Cas Lek Cesk; 2005; 144(9):597-600; discussion 600-1. PubMed ID: 16193937 [TBL] [Abstract][Full Text] [Related]
30. Neuroimaging and neurologic complications after organ transplantation. Zivković S J Neuroimaging; 2007 Apr; 17(2):110-23. PubMed ID: 17441832 [TBL] [Abstract][Full Text] [Related]
32. Oral and dental problems in the organ transplant patient. Seymour RA; Thomason JM; Ellis JS Dent Update; 1994 Jun; 21(5):209-12. PubMed ID: 7875351 [TBL] [Abstract][Full Text] [Related]
33. Bone disorders after organ transplantation. Goffin E; Devogelaer JP Transplant Proc; 2005; 37(6):2832-3. PubMed ID: 16182824 [TBL] [Abstract][Full Text] [Related]
34. Cyclosporine downregulates Fas ligand expression on vascular endothelial cells: implication for accelerated vasculopathy by immunosuppressive therapy. Sata M; Walsh K Biochem Biophys Res Commun; 1999 Sep; 263(2):430-2. PubMed ID: 10491310 [TBL] [Abstract][Full Text] [Related]
36. For organ transplant recipients, cancer threatens long-term survival. Ross K J Natl Cancer Inst; 2007 Mar; 99(6):421-2. PubMed ID: 17374827 [No Abstract] [Full Text] [Related]
37. Outcomes of pregnancy and the management of immunosuppressive agents to minimize fetal risks in organ transplant patients. Huynh LA; Min DI Ann Pharmacother; 1994 Dec; 28(12):1355-7. PubMed ID: 7696726 [No Abstract] [Full Text] [Related]
38. [Cutaneous complications after organ transplantation]. Gjersvik PJ Tidsskr Nor Laegeforen; 1999 Oct; 119(25):3789-92. PubMed ID: 10574059 [TBL] [Abstract][Full Text] [Related]
39. Bone Loss after Solid Organ Transplantation: A Review of Organ-Specific Considerations. Kim KJ; Ha J; Kim SW; Kim JE; Lee S; Choi HS; Hong N; Kong SH; Ahn SH; Park SY; Baek KH Endocrinol Metab (Seoul); 2024 Apr; 39(2):267-282. PubMed ID: 38693817 [TBL] [Abstract][Full Text] [Related]